Prempro news | Breaking Prempro news | Prempro

Wyeth's second-quarter profit up 18 percent

...Bernard Poussot, head of global pharmaceutical operations, said the low-dose Wyeth just launched ads urging women to talk to their doctors about menopause symptoms, something many stopped doing after the negative studies were released.

The company repeated its recent full-year guidance of earnings of $2.80 to $2.90 per share, excluding any one-time costs.

Analysts are forecasting $2.86.

"If current strong business trends continue, full-year earnings are more likely to approach or exceed the upper end," Martin said.

That's despite plans to increase research spending substantially in the second half of the year.

Wyeth shares rose 75 cents, or 1.7 percent, to $45.75 in morning trading on the New York Stock Exchange, above their 52-week high of $45.76 reached earlier this month.

- http://www.wyeth.com email this print this reprint or license this News Copyright ...

Read more...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news

Health and Fitness